Master Protocol For Metastatic Breast Cancer Needs To Adapt To Rational Combinations
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Beyond saving money and creating efficiencies, stakeholders want a master trial to foster true innovation in metastatic breast cancer treatment. Various ways to deal with dosing and other challenges in testing rational combinations of different interventions were discussed at recent workshop.